Current medical news and unique business news for anyone who cares about the healthcare industry.
More conflicts. But now a solution? Half of those involved in writing recent treatment guidelines for heart patients reported a conflict of interest, such as owning companies’ stocks. But one of the study’s authors thought the most important finding was about the other half of experts who weren’t tainted. That group rebuts the argument that there are not enough experienced experts who are independent, Dr. James N. Kirkpatrick said.
Roche not for sale. But Abbott? Roche leadership quashed discussions of a sale, while an Abbott analyst suggested that company would be better off breaking up. Abbott management doesn’t seem to agree, however.
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
RepubliCare = expensive. Republican alternatives to “Obamacare” would only cut less than .6 percent from federal healthcare spending, according to a Bloomberg study. “None of these proposals get to the heart of what the issue is, which is to really address cost,” says Ashish Kaura, a health-care analyst with Booz & Co. “They nibble around at the margins.”
When more nurses matter. More nurses are important in the ICU, but increased nurse staffing doesn’t have as big an impact in “safety net” hospitals, according to a new study.
A single-cell cancer detector… has been developed by professors at Harvard and MIT.
Stop talking about funding in dollars. The proper way to describe financing is now based on colors.
